Invention Grant
- Patent Title: Factor IX polypeptides and methods of use thereof
-
Application No.: US14982934Application Date: 2015-12-29
-
Publication No.: US09867873B2Publication Date: 2018-01-16
- Inventor: Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
- Applicant: Bioverativ Therapeutics Inc.
- Applicant Address: US MA Waltham
- Assignee: BIOVERATIV THERAPEUTICS INC.
- Current Assignee: BIOVERATIV THERAPEUTICS INC.
- Current Assignee Address: US MA Waltham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K14/755
- IPC: C07K14/755 ; A61K38/48 ; A61K39/395 ; C12N9/96 ; A61K38/38 ; C07K16/18 ; C12N9/64 ; C07K14/76 ; A61K9/00 ; A61K47/48
Abstract:
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Public/Granted literature
- US20160257943A1 Factor IX Polypeptides and Methods of Use Thereof Public/Granted day:2016-09-08
Information query
